InsiderDB

SEC EDGAR · Company announcement

AIM: Company disclosure

Filed 8-K for an event or period dated 2026-11-05. Company disclosure.

Follow AIM
Became public
Nov 5, 2026, 9:14 AM EST
Event / period date
Nov 5, 2026
Collected
Nov 18, 2026, 8:37 AM EST

Why this is connected

This filing identifies AIM ImmunoTech Inc. as the issuer of the security. The company's SEC identifier connects it to AIM.

Press Release, dated November 5, 2026. ↗

Source evidence

Read the source excerpt or record
Item 7.01 Regulation FD Disclosure. Furnished herewith as Exhibits 99.1 and 99.2, respectively, are a Corporate Presentation of AIM ImmunoTech Inc. (the “Company”) titled “The Ampligen Opportunity” and a press release issued by the Company on November 5, 2026. The information furnished under this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing. Cautionary Note Regarding Forward-Looking Statements This Current Report on Form 8-K, including Exhibits 99.1 and 99.2, contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements include, but are not limited to, statements relating to: the potential of Ampligen to enhance and extend clinical benefit; the potential of combined treatment approaches to pancreatic cancer; expectations regarding Ampligen’s mechanism of action; the timing and outcome of future clinical trials, regulatory submissions, or government funding decisions; and the Company’s business strategy and objectives. Words such as “believe,” “may,” “will,” “could,” “should,” “estimate,” “anticipate,” “intend,” “expect,” “potential,” “plan,” “project,” and similar expressions identify forward-looking statements. These statements are based on current expectations and assumptions that may prove incorrect, and involve risks and uncertainties that could cause actual results to diffe

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.